Herein, we report our multi‐disciplinary tertiary centre experience in managing these patients, review the literature for each treatment modality and propose an algorithm for the stepwise management of hypoglycaemia in patients with hyperinsulinemia caused by an insulin secreting neuroendocrine tumour. Here, INS is linked to neuroendocrine neoplasm.